Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reid Shaw

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cell Systems|March 30, 2018
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome AtlasFranz X Schaub, Varsha Dhankani, Ashton C Berger, et al.
Ebiomedicine|September 14, 2020
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancerGoldie Y L Lui, Reid Shaw, Franz X Schaub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck CancerChang Xu, Olga Nikolova, Ryan S Basom, et al.
Blood Advances|February 19, 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapyReid Shaw, James J Yoon, Hannah Johnston, et al.
Cancer Discovery|March 24, 2017
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Benjamin D Hopkins, Davide Prandi, et al.
The Journal of Experimental Medicine|May 5, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancerRenuka Raman, Jacques A Villefranc, Timothy M Ullmann, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell Systems|March 30, 2018
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome AtlasFranz X Schaub, Varsha Dhankani, Ashton C Berger, et al.
Ebiomedicine|September 14, 2020
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancerGoldie Y L Lui, Reid Shaw, Franz X Schaub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck CancerChang Xu, Olga Nikolova, Ryan S Basom, et al.
Blood Advances|February 19, 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapyReid Shaw, James J Yoon, Hannah Johnston, et al.
Cancer Discovery|March 24, 2017
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Benjamin D Hopkins, Davide Prandi, et al.
The Journal of Experimental Medicine|May 5, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancerRenuka Raman, Jacques A Villefranc, Timothy M Ullmann, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
Pageof 2